FDA grants expanded approval for Bristol Myers Squibb anemia therapy - NJBIZ

“The approval of Reblozyl in the first-line treatment of anemia for patients with lower-risk MDS represents a crucial step in making transfusion independence possible for more patients," said Tracey Iraca, executive director of the MDS Foundation.

Bryan Bloom, Author at NJBIZ

Lee & Associates New Jersey relocates to Elmwood Park - NJBIZ

Bristol Myers Squibb - Bristol Myers Squibb Awards Nearly $8 Million in New Health Equity Grants to Improve Access to Care for Medically Underserved Patients in U.S.

Crow Holdings completes $164M sale of Franklin Township logistics property - NJBIZ

U.S. FDA approves new Bristol Myers cancer immunotherapy

U.S. Food and Drug Administration Approves Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel), a New CAR T Cell Therapy for Adults with Relapsed or Refractory Large B-cell Lymphoma

U.S. FDA Approves Bristol Myers Squibb's CAR T Cell Therapy Breyanzi® for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy

Cushman & Wakefield arranges $23.25M Moorestown industrial sale - NJBIZ

NJ companies give, and get, COVID-19 donations - NJBIZ

Carlyle buying broadcasting, streaming firm LiveU for $400M - NJBIZ